Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Barbara Galaini Biography and Net Worth

Insider of Tyme Technologies

Barbara Galaini has been appointed as Principal Financial Officer, Principal Accounting Officer, Corporate Controller of the Company effective 9/30/2020. She has served as the Principal Accounting Officer of Tyme since August 2018 and the Company’s Corporate Controller since April 2018. Before joining the Company, Ms. Galaini was the Chief Accounting Officer of the Americas for Avolon Holdings, a global aircraft leasing company from April 4, 2017 to April 4, 2018. Prior to that she was employed at CIT Bank for more than 25 years in various financial roles, including segment Chief Financial Officer and most recently as Senior Vice President and Controller of the Transportation Finance unit since 2009. Ms. Galaini has extensive experience in structured finance and leasing transactions, acquisition and divestitures and finance integration.

How do I contact Barbara Galaini?: The corporate mailing address for Ms. Galaini and other Tyme Technologies executives is 17 STATE STREET 7TH FLOOR, NEW YORK NY, 10004. Tyme Technologies can also be reached via phone at (212) 461-2315 and via email at [email protected]. Learn More on Barbara Galaini's contact information.
Has Barbara Galaini been buying or selling shares of Tyme Technologies?: Barbara Galaini has not been actively trading shares of Tyme Technologies during the past quarter. Most recently, on Friday, November 12th, Barbara Galaini bought 10,000 shares of Tyme Technologies stock. The stock was acquired at an average cost of $0.95 per share, with a total value of $9,500.00. Learn More on Barbara Galaini's trading history.
Who are Tyme Technologies' active insiders?: Tyme Technologies' insider roster includes James Biehl (Insider), David Carberry (Director), Michael Demurjian (Major Shareholder), Barbara Galaini (Insider), Steve Hoffman (Insider), and Jan Van Rornout (Insider). Learn More on Tyme Technologies' active insiders.

Barbara Galaini Insider Trading History at Tyme Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/12/2021	Buy	10,000	$0.95	$9,500.00
6/14/2019	Buy	10,000	$1.00	$10,000.00

Barbara Galaini Buying and Selling Activity at Tyme Technologies

Tyme Technologies Company Overview

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey.

Today's Range

Now: $0.31

$0.29

$0.32

50 Day Range

MA: $0.30

$0.24

$0.35

2 Week Range

Now: $0.31

$0.22

$1.14

Volume

2,678,186 shs

Average Volume

1,009,732 shs

Market Capitalization

$53.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93